🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎥 L. Charleston IV, MD, MSc, FAHS (MSU College of Human Medicine) proposes a definition for special populations in #Headache medicine, including those with headache disease who experience increased barriers to healthcare equity and those underrepresented in research: 👉 ow.ly/a6TL50SphCa #AANAM #NeuroTwitter

Have u ever wanted 2 make a difference that could create a ripple effect 2 positively impact the lives of others in need? #Migraine is too often under diagnosed & misunderstood & #disparities exist. I’m grateful 4 this pub. & to those who assisted w this. #meded #healthequity 🙏🏾

Honored to moderate & present w this phenomenal multi-disciplinary panel sharing on: More Than A #Headache: The underdiagnosis & undertreatment reality of #migraine [disease]. A Symposium @ the National Medical Association in #NYC today! Pfizer Inc. Cynthia E. Armand, MD HL O'Brien Jessica Shepherd, MD, MBA, FACOG Dr. Joe

Read all about it! ePub Today!!! “The #headache #research priorities: Research goals from the American Headache Society and an international multistakeholder expert group.” American Headache Society Headache Journal American Academy of Neurology American Neurological Association MSU College of Human Medicine CoalitionCHAMP pubmed.ncbi.nlm.nih.gov/39149968/

Free Access: The American Headache Society & an international multistakeholder expert group published #headache research priorities to help guide investigators over the next 10 yrs & and serve as benchmarks to measure progress over time …adachejournal.onlinelibrary.wiley.com/doi/full/10.11… Todd Schwedt, M.D., FAHS Amynah Pradhan et al

We spoke to Amynah Pradhan about the recently published American Headache Society #headache research priorities! Listen to the interview linked below to find out the details behind this important work. Free access manuscript: …adachejournal.onlinelibrary.wiley.com/doi/full/10.11… youtu.be/-zAKWygJuko

Still warm off the digital press : A phase 2 proof of concept trial confirms that an infusion blocking #PACAP can prevent #migraine days! Outstanding #research by Messoud Ashina and colleagues. Human Migraine Research Unit nejm.org/doi/full/10.10…

Apply today for the 2025 International #HeadacheAcademy! Join us Feb 20-22 in Los Angeles, CA. Open to PGY-3+ Residents, Fellows, and clinicians/researchers in the US, Canada, & Latin America. View full eligibility criteria and apply by Oct 27: bit.ly/3zoqLc4

So humbled &honored to receive the 2024 American Neurological Association’s Dr. Audrey S. Penn Lectureship Award. 🙏🏾🙏🏾 Grateful 4 mentors, colleagues, teachers, students, patients, caregivers, ANA IDEAS committee, UMichNeurosciences MSU College of Human Medicine my family and my God! Lots of work yet to do! Blessings to all!

Breaking News on #Behavioral #Interventions for #Migraine #Prevention: The Evidence-based Practice Center (EPC) Program @ Agency for Healthcare Research and Quality (AHRQ), in partnership with the The Patient-Centered Outcomes Research Institute has completed an evidence review. The final report effectivehealthcare.ahrq.gov/products/behav…

I am grateful! Thank God! Indeed, I have so many things to be grateful for! My gratitude for my wife, children and family is tremendous! and here’s one on the professional side: I’m honored to be selected as the 2024 recipient of the 2024 American Headache Society DEI award. Much work to do!

Wonderful seeing L. Charleston IV, MD, MSc, FAHS accept the American Headache Society #DEI Award for his work defining underserved populations in #neurology and #headache and how to best frame interventions for a variety of populations. 👏👏👏 #AHSAM

SNMA is thrilled to announce TWO amazing research opportunities just for you! These programs are perfect for growing your skills, building your CV, and taking your student research journey to the next level! Scan the flyer QR codes to learn more and apply!

I remain honored & grateful to be the #AHSAZ2024 DEI Awardee & hope provided much value in defining “Special Populations”, exploring #Health #Equity in #AI, & Research Priorities to address inequities and access in Headache Medicine in my presentation!#MovingForward American Headache Society

Learn the latest about the current evaluation and treatment in headache from MSU College of Human Medicine's L. Charleston IV, MD, MSc, FAHS at Contemporary Neurology 2025. Register for #CN2025 ▶️ bit.ly/4bztTyP

I appreciate the opportunity to share. 🙏🏾

A wonderful time for an update in #Migraine #Treatment

A few new(er) US FDA approvals for #Migraine 1) AtzumiTM (Dihydroergotamine) Nasal Powder (Satsuma) (acute Tx) 2) Combination of meloxicam and rizatriptan, Symbravo (Axsome) (acute Tx) 3) CT-132, the first prescription digital therapeutic for the preventive Tx migraine 👏🏾👏🏾

Honored to be part of the team on this important work and very grateful for its publication! We found that higher levels of lifetime perceived #discrimination & discrimination in medical settings were significantly associated with worse #migraine-specific quality of life.

There were many lessons, challenges overcome- much learning with this project! Although I’ve been blessed to participate & present many abstracts, when I received this acceptance email, my heart was especially full of #gratitude and #joy! Major thank you mentors & participants!